Large-scale testing (Phase 3)Study completedNCT00403767
What this trial is testing
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation
Who this might be right for
Atrial FibrillationStrokeEmbolism
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14,269